Canada Vigilance Program - Collecting and Assessing Adverse Reaction Reports
Data and Resources
-
HTML from...HTML
The Canada Vigilance Program collects and assesses reports of suspected...
Additional Info
| Field | Value |
|---|---|
| Last Updated | January 20, 2026, 00:32 (UTC) |
| Created | January 16, 2026, 20:36 (UTC) |
| crisis_categories | Événements climatiques extrêmes |
| criticality_level | Élevé |
| data_formats | HTML |
| description_fr | The Canada Vigilance Program collects and assesses reports of suspected adverse reactions to marketed health products in Canada, including prescription and non-prescription medications; natural health products; biologically derived products such as vaccines and fractionated blood products; cells, tissues and organs; radiopharmaceuticals; and disinfectants and sanitizers with disinfectant claims. |
| fair_openness | Level 2 - Machine-readable |
| geographic_scope | Canada |
| opening_level | Donnée ouverte au grand public |
| sector | health_and_safety |
| sensitivity_level | Faible |
| source_inventaire | Inventaire_F |
| source_url | https://geoegl.msp.gouv.qc.ca/igo2/apercu-qc/?context=avp |
| title_fr | Canada Vigilance Program - Collecting and Assessing Adverse Reaction Reports |
| update_frequency | Selon les besoins |